
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular Signature of Tumor-Associated High Endothelial Venules That Can Predict Breast Cancer Survival
Junko Sawada, Nobuyoshi Hiraoka, Rongsu Qi, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 4, pp. 468-481
Open Access | Times Cited: 27
Junko Sawada, Nobuyoshi Hiraoka, Rongsu Qi, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 4, pp. 468-481
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Pathological angiogenesis: mechanisms and therapeutic strategies
Andrew C. Dudley, Arjan W. Griffioen
Angiogenesis (2023) Vol. 26, Iss. 3, pp. 313-347
Open Access | Times Cited: 217
Andrew C. Dudley, Arjan W. Griffioen
Angiogenesis (2023) Vol. 26, Iss. 3, pp. 313-347
Open Access | Times Cited: 217
High endothelial venules in cancer: Regulation, function, and therapeutic implication
Gerlanda Vella, Yichao Hua, Gabriele Bergers
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 527-545
Open Access | Times Cited: 38
Gerlanda Vella, Yichao Hua, Gabriele Bergers
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 527-545
Open Access | Times Cited: 38
Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response
Qianqian Zhang, Suhui Wu
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 36
Qianqian Zhang, Suhui Wu
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 36
Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances
Lianyu Zhao, Song Jin, Shengyao Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 15
Lianyu Zhao, Song Jin, Shengyao Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 15
Anti‐angiogenic therapy enhances cancer immunotherapy: Mechanism and clinical application
Anqi Li, Jian‐Hong Fang
Deleted Journal (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 10
Anqi Li, Jian‐Hong Fang
Deleted Journal (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 10
Novel Implication of the Basement Membrane for Breast Cancer Outcome and Immune Infiltration
W. H. Tian, Yongzhou Luo, Yuhui Tang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 5, pp. 1645-1663
Open Access | Times Cited: 18
W. H. Tian, Yongzhou Luo, Yuhui Tang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 5, pp. 1645-1663
Open Access | Times Cited: 18
Tumor Vasculature as an Emerging Pharmacological Target to Promote Anti-Tumor Immunity
Hong‐Tai Tzeng, Yu-Jie Huang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4422-4422
Open Access | Times Cited: 14
Hong‐Tai Tzeng, Yu-Jie Huang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4422-4422
Open Access | Times Cited: 14
Tspan protein family: focusing on the occurrence, progression, and treatment of cancer
Huhu Zhang, Qinghang Song, Kaiwen Shang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Huhu Zhang, Qinghang Song, Kaiwen Shang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Unveiling the unique role of TSPAN7 across tumors: a pan-cancer study incorporating retrospective clinical research and bioinformatic analysis
Bingnan Lu, Yifan Liu, Yuntao Yao, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Bingnan Lu, Yifan Liu, Yuntao Yao, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes
Yikan Sun, Eloy Yinwang, Shengdong Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Yikan Sun, Eloy Yinwang, Shengdong Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Spatially resolved atlas of breast cancer uncovers intercellular machinery of venular niche governing lymphocyte extravasation
Xin Wang, Zhanyu Wang, Qijun Liao, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Xin Wang, Zhanyu Wang, Qijun Liao, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Immunomodulation by endothelial cells: prospects for cancer therapy
Halima Alnaqbi, Lisa M. Becker, Mira Mousa, et al.
Trends in cancer (2024) Vol. 10, Iss. 11, pp. 1072-1091
Closed Access | Times Cited: 3
Halima Alnaqbi, Lisa M. Becker, Mira Mousa, et al.
Trends in cancer (2024) Vol. 10, Iss. 11, pp. 1072-1091
Closed Access | Times Cited: 3
Tertiary Lymphoid Structures (TLSs) and Stromal Blood Vessels Have Significant and Heterogeneous Impact on Recurrence, Lymphovascular and Perineural Invasion amongst Breast Cancer Molecular Subtypes
ALINA CRISTINA BARB, Mihaela Pasca Fenesan, Marilena Pirtea, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1176-1176
Open Access | Times Cited: 9
ALINA CRISTINA BARB, Mihaela Pasca Fenesan, Marilena Pirtea, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1176-1176
Open Access | Times Cited: 9
High endothelial venule is a prognostic immune‐related biomarker in patients with resected intrahepatic cholangiocarcinoma
Yan Zhou, Qian Gu, Linxi Zhu, et al.
Cell Proliferation (2023) Vol. 56, Iss. 12
Open Access | Times Cited: 8
Yan Zhou, Qian Gu, Linxi Zhu, et al.
Cell Proliferation (2023) Vol. 56, Iss. 12
Open Access | Times Cited: 8
Heterogeneity of tertiary lymphoid structures in cancer
Xin You, Kristina Koop, Andreas Weigert
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Xin You, Kristina Koop, Andreas Weigert
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Tertiary lymphoid structures: new immunotherapy biomarker
Fangyuan Yang, Jiahe Yang, Meijuan Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Fangyuan Yang, Jiahe Yang, Meijuan Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
A tissue centric atlas of cell type transcriptome enrichment signatures
Philip Dusart, Sofia Öling, Eike C. Struck, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Philip Dusart, Sofia Öling, Eike C. Struck, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Integrated analysis of multiple transcriptomic approaches and machine learning integration algorithms reveals high endothelial venules as a prognostic immune-related biomarker in bladder cancer
Jinge Zhang, Yuan Huang, Xing Tan, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112184-112184
Closed Access | Times Cited: 2
Jinge Zhang, Yuan Huang, Xing Tan, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112184-112184
Closed Access | Times Cited: 2
Intratumoral high endothelial venules in solid tumors: a pooled study
Bin Wang, Han Yin, Jie Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Bin Wang, Han Yin, Jie Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
LTβR Agonism Promotes Anti-Tumor Immune Responses via Modulation of the Tumor Microenvironment
Disi An, Guoying Chen, Wei‐Yi Cheng, et al.
Cancer Research (2024) Vol. 84, Iss. 23, pp. 3984-4001
Closed Access | Times Cited: 2
Disi An, Guoying Chen, Wei‐Yi Cheng, et al.
Cancer Research (2024) Vol. 84, Iss. 23, pp. 3984-4001
Closed Access | Times Cited: 2
Regulation, maintenance, and remodeling of high endothelial venules in homeostasis, inflammation, and cancer
Nancy H. Ruddle
Current Opinion in Physiology (2023) Vol. 36, pp. 100705-100705
Open Access | Times Cited: 5
Nancy H. Ruddle
Current Opinion in Physiology (2023) Vol. 36, pp. 100705-100705
Open Access | Times Cited: 5
Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023
Yiwen Bao, Zeming Mo, Shuang Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Yiwen Bao, Zeming Mo, Shuang Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Multi-omics consensus portfolio to refine the classification of lung adenocarcinoma with prognostic stratification, tumor microenvironment, and unique sensitivity to first-line therapies
Yanmei Zou, Chenlin Cao, Yali Wang, et al.
Translational Lung Cancer Research (2022) Vol. 11, Iss. 11, pp. 2243-2260
Open Access | Times Cited: 5
Yanmei Zou, Chenlin Cao, Yali Wang, et al.
Translational Lung Cancer Research (2022) Vol. 11, Iss. 11, pp. 2243-2260
Open Access | Times Cited: 5
4-nitroquinoline 1-oxide-induced oral epithelial lesions exhibit time- and stage-dependent changes in the tumor immune microenvironment
Kjersti Sellæg, Ruth Schwienbacher, Mathias Kranz, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Kjersti Sellæg, Ruth Schwienbacher, Mathias Kranz, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Methods for Selective Gene Expression Profiling in Single Tertiary Lymphoid Structure Using Laser Capture Microdissection
Claudia Gutierrez-Chavez, Samantha Knockaert, Marie‐Caroline Dieu‐Nosjean, et al.
Methods in molecular biology (2024), pp. 107-126
Closed Access
Claudia Gutierrez-Chavez, Samantha Knockaert, Marie‐Caroline Dieu‐Nosjean, et al.
Methods in molecular biology (2024), pp. 107-126
Closed Access